{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:45:09Z","timestamp":1791510309395,"version":"4.3.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-DAAD"],"award-info":[{"award-number":["NRF-DAAD"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000308","name":"Carnegie Corporation of New York","doi-asserted-by":"publisher","award":["Carnegie Corporation of New York"],"award-info":[{"award-number":["Carnegie Corporation of New York"]}],"id":[{"id":"10.13039\/100000308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007081","name":"Fondation L\u2019Or\u00e9al","doi-asserted-by":"publisher","award":["Fondation L\u2019Or\u00e9al"],"award-info":[{"award-number":["Fondation L\u2019Or\u00e9al"]}],"id":[{"id":"10.13039\/501100007081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Genetic investigations of inherited neuromuscular disorders in Africans, have been neglected. We aimed to summarise the published data and comment on the genetic evidence related to inherited neuropathies (Charcot-Marie-Tooth disease (CMT)), hereditary spastic paraplegias (HSP) and spinal muscular atrophy (SMA) in Africans.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed was searched for relevant articles and manual checking of references and review publications were performed for African-ancestry participants with relevant phenotypes and identified genetic variants. For each case report we extracted phenotype information, inheritance pattern, variant segregation and variant frequency in population controls (including up to date frequencies from the gnomAD database).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>For HSP, 23 reports were found spanning the years 2000\u20132019 of which 19 related to North Africans, with high consanguinity, and six included sub-Saharan Africans. For CMT, 19 reports spanning years 2002\u20132021, of which 16 related to North Africans and 3 to sub-Saharan Africans. Most genetic variants had not been previously reported. There were 12 reports spanning years 1999\u20132020 related to <jats:italic>SMN1<\/jats:italic>-SMA caused by homozygous exon 7\u2009\u00b1\u20098 deletion. Interestingly, the population frequency of heterozygous <jats:italic>SMN1<\/jats:italic>-exon 7 deletion mutations appeared 2\u2009\u00d7\u2009lower in Africans compared to Europeans, in addition to differences in the architecture of the <jats:italic>SMN2<\/jats:italic> locus which may impact <jats:italic>SMN1<\/jats:italic>-SMA prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Overall, genetic data on inherited neuromuscular diseases in sub-Saharan Africa, are sparse. If African patients with rare neuromuscular diseases are to benefit from the expansion in genomics capabilities and therapeutic advancements, then it is critical to document the mutational spectrum of inherited neuromuscular disease in Africa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Highlights<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>Review of genetic variants reported in hereditary spastic paraplegia in Africans<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Review of genetic variants reported in genetic neuropathies in Africans<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Review of genetic underpinnings of spinal muscular atrophies in Africans<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Assessment of pathogenic evidence for candidate variants<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02280-2","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T23:02:50Z","timestamp":1648162970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A review of the genetic spectrum of hereditary spastic paraplegias, inherited neuropathies and spinal muscular atrophies in Africans"],"prefix":"10.1186","volume":"17","author":[{"given":"Amokelani C.","family":"Mahungu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nomakhosazana","family":"Monnakgotla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8999-718X","authenticated-orcid":false,"given":"Jeannine M.","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"2280_CR1","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/jnnp-2020-323016","volume":"91","author":"MM Reilly","year":"2020","unstructured":"Reilly MM, Rossor AM. Humans: the ultimate animal models. J Neurol Neurosurg Psychiatry. 2020;91:1132\u20136. https:\/\/doi.org\/10.1136\/jnnp-2020-323016.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2280_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/S11910-019-0930-2","volume":"19","author":"M Boutry","year":"2019","unstructured":"Boutry M, Morais S, Stevanin G. Update on the genetics of spastic paraplegias. Curr Neurol Neurosci Rep. 2019;19:18. https:\/\/doi.org\/10.1007\/S11910-019-0930-2.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2280_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jns.2016.05.006","volume":"366","author":"RO Akinyemi","year":"2016","unstructured":"Akinyemi RO, Owolabi MO, Oyeniyi T, Ovbiagele B, Arnett DK, Tiwari HK, et al. Neurogenomics in Africa: perspectives, progress, possibilities and priorities. J Neurol Sci. 2016;366:213\u201323. https:\/\/doi.org\/10.1016\/j.jns.2016.05.006.","journal-title":"J Neurol Sci"},{"key":"2280_CR4","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1251546","volume":"344","author":"E Matovu","year":"2014","unstructured":"Matovu E, Bucheton B, Chisi J, Enyaru J, Hertz-Fowler C, Koffi M, et al. Enabling the genomic revolution in Africa. Science. 2014;344:1346\u20138. https:\/\/doi.org\/10.1126\/science.1251546.","journal-title":"Science"},{"key":"2280_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41585-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint quantified from variation in 141,456 humans. Nature. 2020;581:434\u201344. https:\/\/doi.org\/10.1038\/s41585-020-2308-7.","journal-title":"Nature"},{"key":"2280_CR6","doi-asserted-by":"publisher","unstructured":"Den Dunnen JT, Dalgleish R,\u00a0Maglott\u00a0DR,\u00a0Hart RK,\u00a0Greenblatt MS,\u00a0McGowan-Jordan\u00a0J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat 2016;37:564\u201369. doi:https:\/\/doi.org\/10.1002\/humu.22981","DOI":"10.1002\/humu.22981"},{"key":"2280_CR7","doi-asserted-by":"crossref","unstructured":"Heckmann JM, Bhigjee A. Tropcial Neurology. In: Farrar J, Hotez P, Junhanss, Kang G, Lalloo D, White N, editors. Manson\u2019s Tropical Infectious Diseases, 23ed. Saunders Ltd 2013, p. 1047\u20131060.","DOI":"10.1016\/B978-0-7020-5101-2.00072-8"},{"key":"2280_CR8","doi-asserted-by":"publisher","unstructured":"Elsayed LEO, Eitazi IZ, Ahmed AE, Stevanin G. Insights into clinical, genetic, and pathological aspects of hereditary spastic paraplegias: a comprehensive overview. Front Mol Biosci. 2021;8: 680899. https:\/\/doi.org\/10.3389\/fmolb.2021.698099.","DOI":"10.3389\/fmolb.2021.698099"},{"key":"2280_CR9","doi-asserted-by":"publisher","unstructured":"Elsayed LEO, Mohammed IN, Hamed AAA, Elseed MA, Johnson A, Mairey M, et al. Hereditary spastic paraplegias: identification of a novel SPG57 variant affecting TFG oligomerization and description of HSP subtypes in Sudan. Eur J Hum Genet. 2016;25:100\u201310. https:\/\/doi.org\/10.1038\/ejhg.2016.108.","DOI":"10.1038\/ejhg.2016.108"},{"key":"2280_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.ajhg.2016.04.002","volume":"98","author":"Z Gan-Or","year":"2016","unstructured":"Gan-Or Z, Bouslam N, Birouk N, Lissouba A, Chambers DB, Veriepe J, et al. Mutations in CAPN1 cause autosomal-recessive hereditary spastic paraplegia. Am J Hum Genet. 2016;98:1038\u201346. https:\/\/doi.org\/10.1016\/j.ajhg.2016.04.002.","journal-title":"Am J Hum Genet"},{"key":"2280_CR11","doi-asserted-by":"publisher","first-page":"6877","DOI":"10.1093\/hmg\/ddv388","volume":"24","author":"US Melo","year":"2015","unstructured":"Melo US, Macedo-Souza LI, Figueiredo T, Muotri AR, Gleeson JG, Coux G, et al. Overexpression of KLC2 due to a homozygous deletion in the non-coding region causes SPOAN syndrome. Hum Mol Genet. 2015;24:6877\u201385. https:\/\/doi.org\/10.1093\/hmg\/ddv388.","journal-title":"Hum Mol Genet"},{"key":"2280_CR12","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1038\/s41467-019-12620-9","volume":"10","author":"M Wagner","year":"2019","unstructured":"Wagner M, Osborn DPS, Gehweiler I, Nagel M, Ulmer U, Bakhtiari S, et al. Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegia. Nat Commun. 2019;10:4790. https:\/\/doi.org\/10.1038\/s41467-019-12620-9.","journal-title":"Nat Commun"},{"key":"2280_CR13","doi-asserted-by":"publisher","unstructured":"Kong XF, Bousfiha A, Rouissi A, Itan Y, Abhyankar A, Bryant V, et al. A novel homozygous p.R1105X mutation of the AP4E1 gene in twins with hereditary spastic paraplegia and mycobacterial disease. PLoS One 2013;8:e58286. doi: https:\/\/doi.org\/10.1371\/journal.pone.0058286 .","DOI":"10.1371\/journal.pone.0058286"},{"key":"2280_CR14","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1212\/01.wnl.0000201185.91110.15","volume":"66","author":"N Elleuch","year":"2006","unstructured":"Elleuch N, Depienne C, Benomar A, Hernandez AM, Ferrer X, Fontaine B, et al. Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology. 2006;66:654\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000201185.91110.15.","journal-title":"Neurology"},{"key":"2280_CR15","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/brain\/awm293","volume":"131","author":"G Stevanin","year":"2008","unstructured":"Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain. 2008;131:772\u201384. https:\/\/doi.org\/10.1093\/brain\/awm293.","journal-title":"Brain"},{"key":"2280_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejmg.2010.10.006","volume":"54","author":"A Abdel Aleem","year":"2011","unstructured":"Abdel Aleem A, Abu-Shahba N, Swistun D, Silhavy J, Bielas SL, Sattar S, et al. Expanding the clinical spectrum of SPG11 gene mutations in recessive hereditary spastic paraplegia with thin corpus callosum. Eur J Med Genet. 2011;54:82\u20135. https:\/\/doi.org\/10.1016\/j.ejmg.2010.10.006.","journal-title":"Eur J Med Genet"},{"key":"2280_CR17","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/brain\/aww111","volume":"139","author":"E Kara","year":"2016","unstructured":"Kara E, Tucci A, Manzoni C, Lynch DS, Elpidorou M, Bettencourt C, et al. Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain. 2016;139:1904\u201318. https:\/\/doi.org\/10.1093\/brain\/aww111.","journal-title":"Brain"},{"key":"2280_CR18","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ajhg.2008.03.004","volume":"82","author":"S Hanein","year":"2008","unstructured":"Hanein S, Martin E, Boukhris A, Byrne P, Goizet C, Hamri A, et al. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am J Hum Genet. 2008;82:992\u20131002. https:\/\/doi.org\/10.1016\/j.ajhg.2008.03.004.","journal-title":"Am J Hum Genet"},{"key":"2280_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.24611","volume":"79","author":"R Schule","year":"2016","unstructured":"Schule R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S, et al. Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol. 2016;79:646\u201358. https:\/\/doi.org\/10.1002\/ana.24611.","journal-title":"Ann Neurol"},{"key":"2280_CR20","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/brain\/awu121","volume":"137","author":"V Pensato","year":"2014","unstructured":"Pensato V, Castellotti B, Gellera C, Pareyson D, Ciano C, Nanetti L, et al. Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain. 2014;137:1907\u201320. https:\/\/doi.org\/10.1093\/brain\/awu121.","journal-title":"Brain"},{"key":"2280_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","volume":"92","author":"E Martin","year":"2013","unstructured":"Martin E, Schule R, Smets K, Rastetter A, Boukhris A, Loureiro JL, et al. Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia. Am J Hum Genet. 2013;92:238\u201344. https:\/\/doi.org\/10.1016\/j.ajhg.2012.11.021.","journal-title":"Am J Hum Genet"},{"key":"2280_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajhg.2013.05.006","volume":"93","author":"A Boukhris","year":"2013","unstructured":"Boukhris A, Schule R, Loureiro JL, Lourenco CM, Mundwiller E, Gonzalez MA, et al. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am J Hum Genet. 2013;93:118\u201323. https:\/\/doi.org\/10.1016\/j.ajhg.2013.05.006.","journal-title":"Am J Hum Genet"},{"key":"2280_CR23","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ajhg.2012.11.001","volume":"91","author":"C Tesson","year":"2012","unstructured":"Tesson C, Nawara M, Salih MA, Rossignol R, Zaki MS, Al Balwi M, et al. Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. Am J Hum Genet. 2012;91:1051\u201364. https:\/\/doi.org\/10.1016\/j.ajhg.2012.11.001.","journal-title":"Am J Hum Genet"},{"key":"2280_CR24","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/brain\/awm014","volume":"130","author":"A Bouhouche","year":"2007","unstructured":"Bouhouche A, Birouk N, Azzedine H, Benomar A, Durosier G, Ente D, et al. Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families. Brain. 2007;130:1062\u201375. https:\/\/doi.org\/10.1093\/brain\/awm014.","journal-title":"Brain"},{"key":"2280_CR25","doi-asserted-by":"publisher","unstructured":"Bouhouche A, Benomar A, Bouslam N, Ouazzani R, Chkili T, Yahyaoui M. Autosomal recessive mutilating sensory neuropathy with spastic paraplegia maps to chromosome 5p15.31\u201314.1. Eur J Hum Genet 2006;14:249\u201352. doi: https:\/\/doi.org\/10.1038\/sj.ejhg.5201537.","DOI":"10.1038\/sj.ejhg.5201537"},{"key":"2280_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1399-0004.2009.01176.x","volume":"75","author":"A Boukhris","year":"2009","unstructured":"Boukhris A, Stevanin G, Feki I, Denora P, Elleuch N, Miladi MI, et al. Tunisian hereditary spastic paraplegias: clinical variability supported by genetic heterogeneity. Clin Genet. 2009;75:527\u201336. https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01176.x.","journal-title":"Clin Genet"},{"key":"2280_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.ejhg.5201922","volume":"16","author":"P Ribai","year":"2008","unstructured":"Ribai P, Depienne C, Fedirko E, Jothy AC, Viveweger C, Hahn-Barma V, et al. Mental deficiency in three families with SPG4 spastic paraplegia. Eur J Hum Genet. 2008;16:97\u2013104. https:\/\/doi.org\/10.1038\/sj.ejhg.5201922.","journal-title":"Eur J Hum Genet"},{"key":"2280_CR28","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1212\/wnl.55.9.1388","volume":"55","author":"A Hentati","year":"2000","unstructured":"Hentati A, Deng HX, Zhai H, Chen W, Yang Y, Hung WY, et al. Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology. 2000;55:1388\u201390. https:\/\/doi.org\/10.1212\/wnl.55.9.1388.","journal-title":"Neurology"},{"key":"2280_CR29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/ajmg.a.61179","volume":"179","author":"G Landoure","year":"2019","unstructured":"Landoure G, Dembele K, Cisse L, Samassekou O, Diarra S, Bocoum A, et al. Hereditary spastic paraplegia type 35 in a family from Mali. Am J Med Genet A. 2019;179:1122\u20135. https:\/\/doi.org\/10.1002\/ajmg.a.61179.","journal-title":"Am J Med Genet A"},{"key":"2280_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/acn3.402","volume":"4","author":"CO Guinto","year":"2017","unstructured":"Guinto CO, Diarra S, Diallo S, Cisse L, Coulibaly T, Diallo SH, et al. A novel mutation in KIF5A in a Malian family with spastic paraplegia and sensory loss. Ann Clin Transl Neurol. 2017;4:272\u20135. https:\/\/doi.org\/10.1002\/acn3.402.","journal-title":"Ann Clin Transl Neurol"},{"key":"2280_CR31","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/humu.22378","volume":"34","author":"G Landoure","year":"2013","unstructured":"Landoure G, Zhu PP, Lourenco CM, Johnson JO, Toro C, Bricceno KV, et al. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Hum Mutat. 2013;34:1357\u201360. https:\/\/doi.org\/10.1002\/humu.22378.","journal-title":"Hum Mutat"},{"key":"2280_CR32","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/ejhg.2013.27","volume":"21","author":"ST de Bot","year":"2013","unstructured":"de Bot ST, Burggraaff RC, Herkert JC, Schelhaas HJ, Post B, Diekstra A, et al. Rapidly deteriorating course in Dutch hereditary spastic paraplegia type 11 patients. Eur J Hum Genet. 2013;21:1312\u20135. https:\/\/doi.org\/10.1038\/ejhg.2013.27.","journal-title":"Eur J Hum Genet"},{"key":"2280_CR33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00415-011-5934-z","volume":"258","author":"A Orlacchio","year":"2011","unstructured":"Orlacchio A, Montieri P, Babalini C, Gaudiello F, Bernardi G, Kawarai T. Late-onset hereditary spastic paraplegia with thin corpus callosum caused by a new SPG3A mutation. J Neurol. 2011;258:1361\u20133. https:\/\/doi.org\/10.1007\/s00415-011-5934-z.","journal-title":"J Neurol"},{"key":"2280_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/practneurol-2015-001095","volume":"15","author":"AM Rossor","year":"2015","unstructured":"Rossor AM, Evans MR, Reilly MM. A practical approach to the genetic neuropathies. Pract Neurol. 2015;15:187\u201398. https:\/\/doi.org\/10.1136\/practneurol-2015-001095.","journal-title":"Pract Neurol"},{"key":"2280_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1474-4422(13)70002-4","volume":"12","author":"CM Centner","year":"2013","unstructured":"Centner CM, Bateman KJ, Heckmann JM. Manifestations of HIV infection in the peripheral nervous system. Lancet Neurol. 2013;12:295\u2013309. https:\/\/doi.org\/10.1016\/S1474-4422(13)70002-4.","journal-title":"Lancet Neurol"},{"key":"2280_CR36","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/jnnp-2019-320717","volume":"90","author":"SC Previtali","year":"2019","unstructured":"Previtali SC, Zhao E, Lazarevic D, Pipitone GB, Fabrizi GM, Manganelli F, et al. Expanding the spectrum of genes responsible for hereditary motor neuropathies. J Neurol Neurosurg Psychiatry. 2019;90:1171\u20139. https:\/\/doi.org\/10.1136\/jnnp-2019-320717.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2280_CR37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nmd.2011.04.013","volume":"21","author":"S Nouioua","year":"2011","unstructured":"Nouioua S, Hamadouche T, Funalot B, Bernard R, Bellatache N, Bouderba R, et al. Novel mutations in the PRX and the MTMR2 genes are responsible for unusual Charcot-Marie-Tooth disease phenotypes. Neuromuscul Disord. 2011;21:543\u201350. https:\/\/doi.org\/10.1016\/j.nmd.2011.04.013.","journal-title":"Neuromuscul Disord"},{"key":"2280_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JND-200518","volume":"8","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Loscher WN, Wanschitz J, Iglseder S. Orphan peripheral neuropathies. J Neuromuscul Disord. 2021;8:1\u201323. https:\/\/doi.org\/10.3233\/JND-200518.","journal-title":"J Neuromuscul Disord"},{"key":"2280_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/brain\/awh021","volume":"127","author":"M Tazir","year":"2004","unstructured":"Tazir M, Azzedine H, Assami S, Sindou P, Nouioua S, Zemmouri R, et al. Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A\/C. Brain. 2004;127:154\u201363. https:\/\/doi.org\/10.1093\/brain\/awh021.","journal-title":"Brain"},{"key":"2280_CR40","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1086\/339274","volume":"70","author":"A De Sandre-Giovannoli","year":"2002","unstructured":"De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, Kassouri N, et al. Homozygous defects in LMNA, encoding lamin A\/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet. 2002;70:726\u201336. https:\/\/doi.org\/10.1086\/339274.","journal-title":"Am J Hum Genet"},{"key":"2280_CR41","doi-asserted-by":"publisher","unstructured":"Hamadouche T, Poitelon Y, Genin E, Chaouch M, Tazir M, Kassouri N, et al. Founder effect and estimation of the age of the c.892C>T (p.Arg298Cys) mutation in LMNA associated to Charcot-Marie-Tooth subtype CMT2B1 in families from North Western Africa. Ann Hum Genet 2008;72:590\u20137. doi: https:\/\/doi.org\/10.1111\/j.1469-1809.2008.00456.x.","DOI":"10.1111\/j.1469-1809.2008.00456.x"},{"key":"2280_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng796","volume":"30","author":"RV Baxter","year":"2002","unstructured":"Baxter RV, Ben Othmane K, Rochelle JM, Stajich JE, Hulette C, Dew-Knight S, et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A\/8q21. Nat Genet. 2002;30:21\u20132. https:\/\/doi.org\/10.1038\/ng796.","journal-title":"Nat Genet"},{"key":"2280_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/ahg.12017","volume":"77","author":"C Boubaker","year":"2013","unstructured":"Boubaker C, Hsairi-Guidara I, Castro C, Ayadi I, Boyer A, Kerkeni E, et al. A novel mutation in FGD4\/FRABIN causes Charcot Marie Tooth disease type 4H in patients from a consanguineous Tunisian family. Ann Hum Genet. 2013;77:336\u201343. https:\/\/doi.org\/10.1111\/ahg.12017.","journal-title":"Ann Hum Genet"},{"key":"2280_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/58428==]","volume":"81","author":"V Delague","year":"2007","unstructured":"Delague V, Jacquier A, Hamadouche T, Poitelon Y, Baudot C, Boccaccio I, et al. Mutations in FGD4 encoding the Rho GDP\/GTP exchange factor FRABIN cause autosomal recessive charcot-marie-tooth type 4H. Am J Hum Genet. 2007;81:1\u201316. https:\/\/doi.org\/10.1086\/58428==].","journal-title":"Am J Hum Genet"},{"key":"2280_CR45","doi-asserted-by":"publisher","unstructured":"De Sandre-Giovannoli A, Delague V, Hamadouche T, Chaouch M, Krahn M, Boccaccio I, et al. Homozygosity mapping of autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy (CMT4H) to a novel locus on chromosome 12p11.21-q13.11. J Med Genet 2005;42:260\u20135. doi: https:\/\/doi.org\/10.1136\/jmg.2004.024364.","DOI":"10.1136\/jmg.2004.024364"},{"key":"2280_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1529-8027.2012.00405.x","volume":"17","author":"C Baudot","year":"2012","unstructured":"Baudot C, Esteve C, Castro C, Poitelon Y, Mas C, Hamadouche T, et al. Two novel missense mutations in FGD4\/FRABIN cause Charcot-Marie-Tooth type 4H (CMT4H). J Peripher Nerv Syst. 2012;17:141\u20136. https:\/\/doi.org\/10.1111\/j.1529-8027.2012.00405.x.","journal-title":"J Peripher Nerv Syst"},{"key":"2280_CR47","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1086\/375034","volume":"72","author":"H Azzedine","year":"2003","unstructured":"Azzedine H, Bolino A, Taieb T, Birouk N, Di Duca M, Bouhouche A, et al. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet. 2003;72:1141\u201353. https:\/\/doi.org\/10.1086\/375034.","journal-title":"Am J Hum Genet"},{"key":"2280_CR48","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/archneur.60.4.598","volume":"60","author":"N Birouk","year":"2003","unstructured":"Birouk N, Azzedine H, Dubourg O, Muriel MP, Benomar A, Hamadouche T, et al. Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene. Arch Neurol. 2003;60:598\u2013604. https:\/\/doi.org\/10.1001\/archneur.60.4.598.","journal-title":"Arch Neurol"},{"key":"2280_CR49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0960-8966(02)00281-X","volume":"13","author":"H Azzedine","year":"2003","unstructured":"Azzedine H, Ruberg M, Ente D, Gilardeau C, Perie S, Wechsler B, et al. Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene. Neuromuscul Disord. 2003;13:341\u20136. https:\/\/doi.org\/10.1016\/S0960-8966(02)00281-X.","journal-title":"Neuromuscul Disord"},{"key":"2280_CR50","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1212\/01.wnl.0000230225.19797.93","volume":"67","author":"H Azzedine","year":"2006","unstructured":"Azzedine H, Ravise N, Verny C, Gabreels-Festen A, Lammens M, Grid D, et al. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology. 2006;67:602\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000230225.19797.93.","journal-title":"Neurology"},{"key":"2280_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1017\/S0317167100007290","volume":"34","author":"A Bouhouche","year":"2007","unstructured":"Bouhouche A, Birouk N, Benomar A, Ouazzani R, Chkili T, Yahyaoui M. A novel GDAP1 mutation P78L responsible for CMT4A disease in three Moroccan families. Can J Neurol Sci. 2007;34:421\u20136. https:\/\/doi.org\/10.1017\/S0317167100007290.","journal-title":"Can J Neurol Sci"},{"key":"2280_CR52","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1212\/01.wnl.0000218304.02715.04","volume":"66","author":"O Dubourg","year":"2006","unstructured":"Dubourg O, Azzedine H, Yaou RB, Pouget J, Barois A, Meininger V, et al. The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V. Neurology. 2006;66:1721\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000218304.02715.04.","journal-title":"Neurology"},{"key":"2280_CR53","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1086\/375039","volume":"72","author":"A Antonellis","year":"2003","unstructured":"Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, Lee-Lin SQ, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet. 2003;72:1293\u20139. https:\/\/doi.org\/10.1086\/375039.","journal-title":"Am J Hum Genet"},{"key":"2280_CR54","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/mus.10344","volume":"27","author":"R Kakar","year":"2003","unstructured":"Kakar R, Ma W, Dutra A, Seltzer WK, Grewal RP. Clinical and genetic analysis of CMT1B in a Nigerian family. Muscle Nerve. 2003;27:628\u201330. https:\/\/doi.org\/10.1002\/mus.10344.","journal-title":"Muscle Nerve"},{"key":"2280_CR55","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.nmd.2021.06.004","volume":"31","author":"RN Villar-Quiles","year":"2021","unstructured":"Villar-Quiles RN, Le VT, Leonard-Louis S, Trang NT, Huong NT, Laddada L, et al. Leukoencephalopathy and conduction blocks in PLEKHG5-associated intermediate CMT disease. Neuromuscul Disord. 2021;31:756\u201364. https:\/\/doi.org\/10.1016\/j.nmd.2021.06.004.","journal-title":"Neuromuscul Disord"},{"key":"2280_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.782","volume":"7","author":"A Yalcouye","year":"2019","unstructured":"Yalcouye A, Diallo SH, Coulibaly T, Cisse L, Diallo S, Samassekou O, et al. A novel mutation in the GARS gene in a Malian family with Charcot-Marie-Tooth disease. Mol Genet Genomic Med. 2019;7: e00782. https:\/\/doi.org\/10.1002\/mgg3.782.","journal-title":"Mol Genet Genomic Med"},{"key":"2280_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/NXG.0000000000000654","volume":"8","author":"M Nel","year":"2022","unstructured":"Nel M, Mahungu AC, Monnakgotla N, Botha GR, Mulder NJ, Wu G, et al. Revealing the mutational spectrum in Southern Africans with amyotrophic lateral sclerosis. Neurology Genetics. 2022;8:1\u201311. https:\/\/doi.org\/10.1212\/NXG.0000000000000654.","journal-title":"Neurology Genetics"},{"key":"2280_CR58","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plante-Bordeneuve","year":"2011","unstructured":"Plante-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10:1086\u201397. https:\/\/doi.org\/10.1016\/S1474-4422(11)70246-0.","journal-title":"Lancet Neurol"},{"key":"2280_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00415-014-7594-2","volume":"262","author":"P McColgan","year":"2015","unstructured":"McColgan P, Viegas S, Gandhi S, Bull K, Tudor R, Sheikh F, et al. Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient. J Neurol. 2015;262:228\u201334. https:\/\/doi.org\/10.1007\/s00415-014-7594-2.","journal-title":"J Neurol"},{"key":"2280_CR60","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1056\/NEJM199702133360703","volume":"336","author":"DR Jacobson","year":"1997","unstructured":"Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med. 1997;336:466\u201373. https:\/\/doi.org\/10.1056\/NEJM199702133360703.","journal-title":"N Engl J Med"},{"key":"2280_CR61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1529-8027.2008.00185.x","volume":"13","author":"J Cassereau","year":"2008","unstructured":"Cassereau J, Lavigne C, Letournel F, Ghali A, Verny C, Dubas F, et al. Hereditary amyloid neuropathy by transthyretin Val107 mutation in a patient of African origin. J Peripher Nerv Syst. 2008;13:251\u20134. https:\/\/doi.org\/10.1111\/j.1529-8027.2008.00185.x.","journal-title":"J Peripher Nerv Syst"},{"key":"2280_CR62","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet. 1999;8:1177\u201383. https:\/\/doi.org\/10.1093\/hmg\/8.7.1177.","journal-title":"Hum Mol Genet"},{"key":"2280_CR63","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s13311-014-0314-x","volume":"12","author":"MA Farrar","year":"2015","unstructured":"Farrar MA, Kiernan MC. The genetics of spinal muscular atrophy: progress and challenges. Neurotherapeutics. 2015;12:290\u2013302. https:\/\/doi.org\/10.1007\/s13311-014-0314-x.","journal-title":"Neurotherapeutics"},{"key":"2280_CR64","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A. 1999;96:6307\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2280_CR65","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1086\/302369","volume":"64","author":"B Wirth","year":"1999","unstructured":"Wirth B, Herz M, Wetter A, Moskau S, Hahnen E, Rudnik-Schoneborn S, et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet. 1999;64:1340\u201356.","journal-title":"Am J Hum Genet"},{"key":"2280_CR66","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.arcped.2011.09.025","volume":"18","author":"A Sbiti","year":"2011","unstructured":"Sbiti A, Ratbi I, Kriouile Y, Sefiani A. Spinal muscular atrophy: frequent cause of congenital hypotonia in Morocco. Arch Pediatr. 2011;18:1261\u20134. https:\/\/doi.org\/10.1016\/j.arcped.2011.09.025.","journal-title":"Arch Pediatr"},{"key":"2280_CR67","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.arcped.2008.04.015","volume":"15","author":"TP They-They","year":"2008","unstructured":"They-They TP, Nadifi S, Dehbi H, Bellayou H, Brik H, Slassi I, et al. Phenotype-genotype correspondence in spinal muscular atrophy in a Moroccan family. Arch Pediatr. 2008;15:1201\u20135. https:\/\/doi.org\/10.1016\/j.arcped.2008.04.015.","journal-title":"Arch Pediatr"},{"key":"2280_CR68","first-page":"133","volume":"108","author":"ML Essawi","year":"2007","unstructured":"Essawi ML, Effat LK, Shanab GM, Al-Ettribi GM, El-Haronui AA, Karim AM. Molecular analysis of SMN1 and NAIP genes in Egyptian patients with spinal muscular atrophy. Bratisl Lek Listy. 2007;108:133\u20137.","journal-title":"Bratisl Lek Listy"},{"key":"2280_CR69","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00415-003-0186-1","volume":"250","author":"A Bouhouche","year":"2003","unstructured":"Bouhouche A, Benomar A, Birouk N, Bouslam N, Ouazzani R, Yahyaoui M, et al. High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients. J Neurol. 2003;250:1209\u201313. https:\/\/doi.org\/10.1007\/s00415-003-0186-1.","journal-title":"J Neurol"},{"key":"2280_CR70","first-page":"465","volume":"84","author":"R Mrad","year":"2006","unstructured":"Mrad R, Dorboz I, Ben Jemaa L, Maazoul F, Trabelsi M, Chaabouni M, et al. Molecular analysis of the SMN1 and NAIP genes in 60 Tunisian spinal muscular atrophy patients. Tunis Med. 2006;84:465\u20139.","journal-title":"Tunis Med"},{"key":"2280_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/903875","volume":"2013","author":"Y Sifi","year":"2013","unstructured":"Sifi Y, Sifi K, Boulefkhad A, Abadi N, Bouderda Z, Cheriet R, et al. Clinical and genetic study of Algerian patients with spinal muscular atrophy. J Neurodegener Dis. 2013;2013: 903875. https:\/\/doi.org\/10.1155\/2013\/903875.","journal-title":"J Neurodegener Dis"},{"key":"2280_CR72","doi-asserted-by":"crossref","unstructured":"Shawky RM, Abd el-Aleem K, Rifaat MM, Moustafa A. Molecular diagnosis of spinal muscular atrophy in Egyptians. East Mediterr Health J 2001;7:229\u201337.","DOI":"10.26719\/2001.7.1-2.229"},{"key":"2280_CR73","first-page":"349","volume":"20","author":"A Lumaka","year":"2009","unstructured":"Lumaka A, Bone D, Lukoo R, Mujinga N, Senga I, Tady B, et al. Werdnig-Hoffmann disease: report of the first case clinically identified and genetically confirmed in central Africa (Kinshasa-Congo). Genet Couns. 2009;20:349\u201358.","journal-title":"Genet Couns"},{"key":"2280_CR74","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ana.24114","volume":"75","author":"M Sangare","year":"2014","unstructured":"Sangare M, Hendrickson B, Sango HA, Chen K, Nofziger J, Amara A, et al. Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa. Ann Neurol. 2014;75:525\u201332. https:\/\/doi.org\/10.1002\/ana.24114.","journal-title":"Ann Neurol"},{"key":"2280_CR75","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.nmd.2007.05.005","volume":"86","author":"G Stevens","year":"1999","unstructured":"Stevens G, Yawitch T, Rodda J, Verhaart S, Krause A. Different molecular basis for spinal muscular atrophy in South African black patients. Am J Med Genet. 1999;86:420\u20136. https:\/\/doi.org\/10.1016\/j.nmd.2007.05.005.","journal-title":"Am J Med Genet"},{"key":"2280_CR76","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1399-0004.2002.620210.x","volume":"62","author":"JM Wilmshurst","year":"2002","unstructured":"Wilmshurst JM, Reynolds L, Van Toorn R, Leisegang F, Henderson HE. Spinal muscular atrophy in black South Africans: concordance with the universal SMN1 genotype. Clin Genet. 2002;62:165\u20138. https:\/\/doi.org\/10.1034\/j.1399-0004.2002.620210.x.","journal-title":"Clin Genet"},{"key":"2280_CR77","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.nmd.2007.05.005","volume":"17","author":"R Labrum","year":"2007","unstructured":"Labrum R, Rodda J, Krause A. The molecular basis of spinal muscular atrophy (SMA) in South African black patients. Neuromuscul Disord. 2007;17:684\u201392. https:\/\/doi.org\/10.1016\/j.nmd.2007.05.005.","journal-title":"Neuromuscul Disord"},{"key":"2280_CR78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fgene.2020.00054","volume":"11","author":"E Vorster","year":"2020","unstructured":"Vorster E, Essop FB, Rodda JL, Krause A. Spinal muscular atrophy in the black South African population: a matter of rearrangement? Front Genet. 2020;11:54. https:\/\/doi.org\/10.3389\/fgene.2020.00054.","journal-title":"Front Genet"},{"key":"2280_CR79","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ana.26009","volume":"89","author":"M Moisse","year":"2021","unstructured":"Moisse M, Zwamborn RAJ, van Vugt J, van der Spek R, van Rheenen W, Kenna B, et al. The effect of SMN gene dosage on ALS risk and disease severity. Ann Neurol. 2021;89:686\u201397. https:\/\/doi.org\/10.1002\/ana.26009.","journal-title":"Ann Neurol"},{"key":"2280_CR80","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/81642","volume":"26","author":"A Tullio-Pelet","year":"2000","unstructured":"Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, et al. Mutant WD-repeat protein in triple-A syndrome. Nat Genet. 2000;26:332\u20135. https:\/\/doi.org\/10.1038\/81642.","journal-title":"Nat Genet"},{"key":"2280_CR81","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/08035250410027706","volume":"93","author":"P Barat","year":"2004","unstructured":"Barat P, Goizet C, Tullio-Pelet A, Puel O, Labessan C, Barthelemy A. Phenotypic heterogeneity in AAAS gene mutation. Acta Paediatr. 2004;93:1257\u20139. https:\/\/doi.org\/10.1080\/08035250410027706.","journal-title":"Acta Paediatr"},{"key":"2280_CR82","doi-asserted-by":"publisher","first-page":"283","DOI":"10.7196\/samj.7785","volume":"104","author":"CH Albertyn","year":"2014","unstructured":"Albertyn CH, Sonderup M, Bryer A, Corrigall A, Meissner P, Heckmann JM. Acute intermittent porphyria presenting as progressive muscular atrophy in a young black man. S Afr Med J. 2014;104:283\u20135. https:\/\/doi.org\/10.7196\/samj.7785.","journal-title":"S Afr Med J"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02280-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T11:59:42Z","timestamp":1648209582000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02280-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2280"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02280-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"30 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}